Pharmacogenetic tests to predict the efficacy of aspirin desensitization in patients with aspirin-exacerbated respiratory diseases; HLA-DQB302

References

• Rajan JP, Wineinger NE, Stevenson DD, White AA. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature. J Allergy Clin Immunol 2014;135(3):676-81
   PubMed Web of Science ®Google Scholar
• Cardet JC, White AA, Barrett NA, et al. Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory disease. J Allergy Clin Immunol Pract 2014;2(2):208-13
   PubMed Web of Science ®Google Scholar
• Nabavi M, Esmaeilzadeh H, Arshi S, et al. Aspirin hypersensitivity in patients with chronic rhinosinusitis and nasal polyposis: Frequency and contributing factors. Am J Rhinol Allergy 2014;28(3):239-43
   PubMed Web of Science ®Google Scholar
• Dursun AB, Woessner KA, Simon RA, et al. Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis. Ann Allergy Asthma Immunol 2008;100(5):420-5
   PubMed Web of Science ®Google Scholar
• Woessner KM, White AA. Evidence-based approach to aspirin desensitization in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2014;133(1):286-7
   PubMed Web of Science ®Google Scholar
• Comert S, Celebioglu E, Yucel T, et al. Aspirin 300 mg/day is effective for treating aspirin-exacerbated respiratory disease. Allergy 2013;68(11):1443-51
   PubMed Web of Science ®Google Scholar
• Stevenson DD, Hankammer MA, Mathison DA, et al. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. J Allergy Clin Immunol 1996;98(4):751-8
   PubMed Web of Science ®Google Scholar
• Swierczynska-Krepa M, Sanak M, Bochenek G, et al. Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study. J Allergy Clin Immunol 2014;134(4):883-90
   PubMed Web of Science ®Google Scholar
• Fruth K, Pogorzelski B, Schmidtmann I, et al. Low-dose aspirin desensitization in individuals with aspirin-exacerbated respiratory disease. Allergy 2013;68(5):659-65
   PubMed Web of Science ®Google Scholar
• Lee JY, Simon RA, Stevenson DD. Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2007;119(1):157-64
   PubMed Web of Science ®Google Scholar
• Rozsasi A, Polzehl D, Deutschle T, et al. Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily. Allergy 2008;63(9):1228-34
   PubMed Web of Science ®Google Scholar
• Park BL, Kim TH, Kim JH, et al. Genome-wide association study of aspirin-exacerbated respiratory disease in a Korean population. Hum Genet 2013;132(3):313-21
   PubMed Web of Science ®Google Scholar
• Esmaeilzadeh H, Nabavi M, Amirzargar AA, et al. HLA-DRB and HLA-DQ genetic variability in patients with aspirin-exacerbated respiratory disease. Am J Rhinology Allerg 2015;29(3):63-9
   PubMed Web of Science ®Google Scholar
• The effect of aspirin desensitization on patients with aspirin-exacerbated respiratory diseases. Available from: https://clinicaltrials.gov/ct2/show/NCT01867281
   Google Scholar
• Esmaeilzadeh H, Nabavi M, Aryan Z, et al. Aspirin desensitization for patients with aspirin exacerbated respiratory disease: A randomized double-blind placebo controlled trial. Clin Immunol 2015. DOI:10.1016/j.clim.2015.05.012
   PubMedGoogle Scholar
• Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008;31(1):143-78
   PubMed Web of Science ®Google Scholar
• Fokkens WJ, Lund VJ, Mullol J, et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl 2012(Suppl 23):1-298
   Google Scholar
• Nabavi M, Arshi S, Bahrami A, et al. Increased level of interleukin-13, but not interleukin-4 and interferon-gamma in chronic rhinosinusitis with nasal polyps. Allergol Immunopathol 2014;42(5):465-71
   PubMed Web of Science ®Google Scholar
• Lee RU, White AA, Ding D, et al. Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2010;105(2):130-5
   PubMed Web of Science ®Google Scholar
• Amirzargar A, Mytilineos J, Farjadian S, et al. Human leukocyte antigen class II allele frequencies and haplotype association in Iranian normal population. Hum Immunol 2001;62(11):1234-8
   PubMed Web of Science ®Google Scholar
• Amirzargar AA, Yalda A, Hajabolbaghi M, et al. The association of HLA-DRB, DQA1, DQB1 alleles and haplotype frequency in Iranian patients with pulmonary tuberculosis. Int J Tuberc Lung Dis 2004;8(8):1017-21
   PubMed Web of Science ®Google Scholar
• Movahedi M, Moin M, Gharagozlou M, et al. Association of HLA class II alleles with childhood asthma and Total IgE levels. Iran J Allergy Asthma Immunol 2008;7(4):215-20
   PubMed Web of Science ®Google Scholar
• Kim S-H, Hur G-Y, Choi J-H, Park H-S. Pharmacogenetics of aspirin-intolerant asthma. Pharmacogenetics 2008;9(1):85-91
   Google Scholar
• Hopkins C, Gillett S, Slack R, et al. Psychometric validity of the 22-item sinonasal outcome test. Clin Otolaryngol 2009;34(5):447-54
   PubMed Web of Science ®Google Scholar
• Shin SW, Park J, Kim YJ, et al. A highly sensitive and specific genetic marker to diagnose aspirin-exacerbated respiratory disease using a genome-wide association study. DNA Cell Biol 2012;31(11):1604-9
   PubMed Web of Science ®Google Scholar
• Stevenson DD. Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. J Allergy Clin Immunol 1984;74(4):617-22
   PubMed Web of Science ®Google Scholar
• Lasky-Su J, Himes BE, Raby BA, et al. HLA-DQ strikes again: genome-wide association study further confirms HLA-DQ in the diagnosis of asthma among adults. Clin Exp Allergy 2012;42(12):1724-33
   PubMed Web of Science ®Google Scholar
• Molnar-Gabor E, Endreffy E, Rozsasi A. HLA-DRB1, -DQA1, and -DQB1 genotypes in patients with nasal polyposis. Laryngoscope 2000;110(3 Pt 1):422-425
   PubMed Web of Science ®Google Scholar
• Ramirez-Anguiano J, Yamamoto-Furusho JK, Barquera R, et al. Association of HLA-DR3 and HLA-DR4 with sinonasal polyposis in Mexican Mestizos. Otolaryngol Head Neck Surg 2006;135(1):90-3
   PubMed Web of Science ®Google Scholar
• Lee HY, Lee JW, Lee KW, et al. The HLA allele marker for differentiating ASA hypersensitivity phenotypes. Allergy 2009;64(9):1385-7
   PubMed Web of Science ®Google Scholar
• Park HS, Kim SH, Sampson AP, et al. The HLA-DPB1*0301 marker might predict the requirement for leukotriene receptor antagonist in patients with aspirin-intolerant asthma. J Allergy Clin Immunol 2004;114(3):688-9
   PubMed Web of Science ®Google Scholar
• Voskamp AL, Prickett SR, Mackay F, et al. MHC class II expression in human basophils: induction and lack of functional significance. PLoS One 2013;8(12):e81777
   PubMedGoogle Scholar
• Wang D, Levasseur-Acker GM, Jankowski R, et al. HLA class II antigens and T lymphocytes in human nasal epithelial cells. Modulation of the HLA class II gene transcripts by gamma interferon. Clin Exp Allerg 1997;27(3):306-14
   PubMed Web of Science ®Google Scholar
• Korosec P, Mavsar N, Bajrovic N, et al. Basophil responsiveness and clinical picture of acetylsalicylic acid intolerance. Intern Arch Allergy Immunol 2011;155(3):257-62
   PubMed Web of Science ®Google Scholar
• Neighbour H. Mechanisms of aspirin-intolerant asthma: identifying inflammatory pathways in the pathogenesis of asthma. Intern Arch Allergy Immunol 2014;163(1):1-2
   PubMed Web of Science ®Google Scholar
• Aryan Z, Compalati E, Canonica GW, Rezaei N. Allergen-specific immunotherapy in asthmatic children: from the basis to clinical applications. Expert Rev Vaccines 2013;12(6):639-59
   PubMed Web of Science ®Google Scholar
• Aryan Z, Holgate ST, Radzioch D, Rezaei N. A new era of targeting the ancient gatekeepers of the immune system: toll-like agonists in the treatment of allergic rhinitis and asthma. Intern Arch Allergy Immunol 2014;164(1):46-63
   PubMed Web of Science ®Google Scholar
• Laidlaw TM, Kidder MS, Bhattacharyya N, et al. Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes. Blood 2012;119(16):3790-8
   PubMed Web of Science ®Google Scholar
• Velazquez JR, Teran LM. Aspirin-intolerant asthma: a comprehensive review of biomarkers and pathophysiology. Clin Rev Allergy Immunol 2013;45(1):75-86
   PubMed Web of Science ®Google Scholar